Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Sunpeaks Ventures, Inc. (OTCBB: SNPK) Featured By Small Cap Investment Research

(EMAILWIRE.COM, April 11, 2012 ) Los Angeles, CA -- Small Cap Investment Research (SmallCapInvestmentResearch.com), a developer, publisher and marketer of independent research products, announced today the release of an updated research report on Sunpeaks Ventures, Inc (OTCBB: SNPK) (“the Company”). Small Cap Investment Research has issued a “STRONG BUY” and a target price of $9.00 on shares of this company.



The report examines the potential continued growth of the Company as it continues to gain market share, and examines the outlook for short and long-term investors. “We were pleased to have the opportunity to report on this company and the industry factors that affect it. The report presents a great overview of the Company and its potential for the long-term with a constantly improving industry dynamic.” – Small Cap Investment Research.



Recently, Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") announced that HDS has signed a Letter of Intent with PharmaLife® for placement of Clotamin® with leading pharmacies in the Russian Federation.



The Letter of Intent outlines the terms and conditions of a proposed transaction that could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation, including product placement with leading wholesalers Imperia-Pharma, the Dr. Stoletov pharmacy chain (414 locations), and other small retail pharmacies associated with Imperia-Pharma. PharmaLife is also expected to secure timely product registration within the Russian Federation for Clotamin distribution and conduct local market research to support a successful product launch.

The entire report can be found on http://www.smallcapinvestmentresearch.com/featured-companies/ .



About Small Cap Investment Research:

Small Cap Investment Research specializes in providing readers with an in-depth analysis of undervalued companies. The company’s role as an independent research analyst firm is to “separate the wheat from the chaff” and help investors receive unbiased, thought-provoking, and quality investment research. SCIR’s philosophy in research is to encapsulate realistic investment ratings, target prices, and forward-looking financial models. The reports contain hard-hitting, meticulously researched facts on companies, their fundamentals, and their industries, validating a company’s prospects and enabling the reader to objectively evaluate the company’s value. The media and savvy investors alike view this model as how investment research needs to be performed devoid of any partiality.



About Sunpeaks Ventures, Inc.:

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.



Forward-Looking Statements

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of Sunpeaks Ventures, Inc. (OTCBB: SNPK) can be found in the filings of Sunpeaks Ventures, Inc. with the U.S. Securities and Exchange Commission.



Release of Liability: Through use of this website viewing or using you agree to hold SCIR, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. We have been compensated six thousand dollars for this SNPK report. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCIR encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCIR makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.



Indepedent Research Investment
Derrick Brazinski
3104567798
dbrazinski@indedentresearchinvestment.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Menopause tied to faster decline in women?s lung function
6 Dec 2016 at 11:09am
By Lisa Rapaport Age-related decline in women?s lung function may speed up during and after menopause, a recent study suggests. Past research has shown that young women can boost their lung function through their mid-twenties by following a healthy lifestyle that includes getting plenty of aerobic exercise and avoiding cigarettes. After that, lung function declines gradually, and the process can be sped up when people smoke or carry excess fat around their midsection.


Cuba, U.S. to discuss detente in wake of Trump election
6 Dec 2016 at 11:06am

HAVANA/WASHINGTON (Reuters) - Cuba and the United States will draw up a roadmap for deepening their detente, the Cuban government said on Tuesday, in a first meeting since the election of Donald Trump as U.S. president and the death of Cuban revolutionary Fidel Castro. Wednesday's fifth U.S.-Cuban bilateral commission comes at a time of increased uncertainty about the future of U.S.-Cuban relations given Trump's promise to end the detente if Cuba did not offer a better "deal." The administration of outgoing U.S. President Barack Obama has pressed American companies to complete additional business deals in Cuba to help further cement the president?s policy by the time Trump takes office on January 20.


Twin Girls Joined at the Chest to Be Separated in 18-Hour Surgery Today
6 Dec 2016 at 10:54am
Twin 2-year-old girls were born conjoined at chest, abdomen.


Philip Morris seeks U.S. approval to market alternative cigarette
6 Dec 2016 at 10:54am

The company's application is the first to seek U.S. approval to market a tobacco product as being less harmful than traditional cigarettes. If approved by the U.S. Food and Drug Administration, the company's iQOS device could give it a significant marketing advantage over alternatives to tobacco products, including electronic cigarettes, which are not allowed to make such a claim. The device electronically heats tobacco to produce a vapor without burning it, and the company claims the vapor has less than 10 percent of the harmful chemicals found in cigarette smoke.



Senate leader pushes for extension of coal miner healthcare
6 Dec 2016 at 10:44am

U.S. Senate Majority Leader Mitch McConnell on Tuesday said he is pushing to extend expiring healthcare benefits for retired coal miners by including a provision in a spending bill Congress hopes to pass this week. In a statement on the Senate floor, McConnell, a Republican from Kentucky, said that in conversations with House of Representatives Speaker Paul Ryan he has insisted that the Continuing Resolution include "a provision to address that issue so these retirees don't lose their healthcare benefit at the end of this year." The fate of the United Mine Workers' health care and pension funds is up in the air as Congress weighs legislation to provide financial support for the soon-expiring benefits, which are at risk of default as coal companies grapple with bankruptcies.



Mugabe praises resilient Zimbabweans, skirts bond notes
6 Dec 2016 at 10:44am

By MacDonald Dzirutwe HARARE (Reuters) - President Robert Mugabe praised Zimbabweans on Tuesday for resilience in the face of economic hardship, in a speech that avoided the recent introduction of "bond notes", a new currency that has raised fears of uncontrolled money-printing. "Let me conclude by paying tribute to our peace-loving people who have endured all manner of economic hardships since we embarked on the historic land-reform programme," Mugabe said to grumbles from opposition benches and shouts of "bond notes". Critics accuse Mugabe, in power since independence from Britain in 1980, of wrecking one of Africa's most promising economies through policies such as the violent seizure of white-owned commercial farms and disastrous printing of money.


Factbox: Contenders for key jobs in Trump's administration
6 Dec 2016 at 10:09am
(Reuters) - Below are people mentioned as contenders for senior roles as U.S. President-elect Donald Trump works to form his administration before taking office on Jan. 20, according to Reuters sources and media reports. Trump has already tapped a number of people for other top jobs in his administration. For a list of posts already filled, see. SECRETARY OF STATE * Mitt Romney, 2012 Republican presidential nominee and former Massachusetts governor * Rudy Giuliani, Republican former mayor of New York City * Bob Corker, Republican U.S. ...


Environmental group takes De Beers Canada to court over mercury
6 Dec 2016 at 10:07am

(Reuters) - An environmental group said on Tuesday it had filed a lawsuit against De Beers Canada, accusing the diamond producer of failing to report toxic levels of mercury and methylmercury at its Victor Diamond mine in northern Ontario. The Wildlands League alleged that De Beers failed to report mercury levels from five out of nine surface water monitoring stations for the creeks next to its open pit mine between 2009 and 2016. This was an offence under the Ontario Water Resources Act, the group said in a statement.


Historians seek reparations for Californians forcibly sterilized
6 Dec 2016 at 9:04am
In a Sacramento government office, historian and lead author Alexandra Minna Stern stumbled across a filing cabinet containing about 20,000 recommendations for eugenics-motivated sterilizations dating from 1919 through 1952. Stern, a professor at the University of Michigan in Ann Arbor, and her colleagues used the documents and actuarial tables to calculate that as many as 831 men, women and children slated for sterilization could still be alive and would be on average almost 88 years old. Many of the typewritten and signed sterilization recommendations were for children, the youngest 7 years old, Stern said in a phone interview.


One drink a day may not always keep the doctor away
6 Dec 2016 at 8:47am

By Lisa Rapaport (Reuters Health) - It?s called ?holiday heart? because it happens to binge drinkers who feel a flutter or irregular heartbeat after too many cocktails at parties. Conventional wisdom, based on plenty of previous research, is that the occasional glass of wine or beer can be good for the heart, reducing the risk of heart disease and stroke as well as death from cardiovascular causes, lead study author Dr. Peter Kistler of the Baker IDI Heart and Diabetes Institute and the Alfred Hospital in Melbourne, Australia, told Reuters Health. For the current study, however, researchers examined data collected on almost 900,000 people and found an 8 percent risk increase for irregular heartbeat with each alcoholic drink consumed per day.


IUDS, implants may be best birth control for women with diabetes
6 Dec 2016 at 8:41am
By Andrew M. Seaman (Reuters Health) - The two most effective hormonal birth control methods for women in general are also excellent options for women with diabetes, according to a new study. Intrauterine devices (IUDs) and contraceptive implants that are placed under the skin, both of which are highly effective, were linked with the lowest risk of blood clots in these higher-risk women. Hormonal contraceptives boost women's risk for clots, which can lead to heart attack and strokes.

U.S. patent agency to weigh rival claims on gene-editing technology
6 Dec 2016 at 8:16am
(Corrects company name to Editas Medicine from Editas Pharmaceuticals in paragraph 15) By Brendan Pierson (Reuters) - The U.S. patent agency on Tuesday will hear arguments in a heated dispute over who was first to invent a revolutionary gene-editing technology known as CRISPR. Hundreds of millions of dollars may be at stake, as the technology promises commercial applications in treating genetic diseases, engineering crops, and other areas. CRISPR works as a type of molecular scissors that can trim away unwanted parts of the genome, and replace them with new stretches of DNA.

Indonesia pledges to protect peatlands to fight climate change, haze
6 Dec 2016 at 7:45am
By Coco Liu HONG KONG (Thomson Reuters Foundation) - Environmental activists hailed on Tuesday Indonesia's ban on converting peatlands into plantations but said enforcement was critical to reducing annual fires that shroud parts of Southeast Asia in choking haze. Indonesia announced on Monday that companies were banned from turning peatlands into palm oil and other types of plantations, and must restore peatlands they have degraded. When peatlands are drained or cleared by fire to make way for plantations, the carbon is released into the atmosphere.

Factbox: Contenders, picks for key jobs in Trump's administration
6 Dec 2016 at 6:51am
(Reuters) - U.S. President-elect Donald Trump said on Monday he would nominate retired neurosurgeon Ben Carson, a presidential rival-turned-supporter to serve as Department of Housing and Urban Development secretary. Below are people mentioned as contenders for senior roles as Trump works to form his administration before taking office on Jan. 20, according to Reuters sources and media reports. See the end of list for posts already filled. ...


Emaciated Yemeni woman now smiles but recovery patchy
6 Dec 2016 at 6:28am

By Mohammed Ghobari SANAA (Reuters) - Images of 18-year-old Saida Ahmad Baghili's emaciated body shocked the world and turned a spotlight on the worsening humanitarian crisis across war-torn Yemen. Now, after weeks of specialist hospital care in the capital Sanaa, though she can still barely speak and sometimes finds eating more difficult than ever, she can at least smile.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC